Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00519194
Status:
TERMINATED
Last Update Posted:
2019-02-19
First Post:
2007-08-20
Brief Title:
CONcomitant eValuation of Epicor Left atRial Therapy for AF
Sponsor:
Abbott Medical Devices
Organization:
Abbott Medical Devices
Study Overview
Official Title:
CONcomitant eValuation of Epicor Left atRial Therapy for AF
Status:
TERMINATED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CONVERT-AF
Brief Summary:
The purpose of this study is to test the safety and efficacy of the Epicor LP Cardiac Ablation System for treating permanent atrial fibrillation during concomitant open chest andor open heart surgery for one of more of the following procedures mitral valve repair or replacement aortic valve repair or replacement tricuspid valve repair or replacement coronary artery bypass surgery or patent foramen ovale PFO closure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None